Fresh analysis reveals that patients who discontinue new GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass far faster than those who halt traditional lifestyle regimens.
Research printed in a major health publication points out that while overweight individuals often shed a large proportion of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing such treatments need to be informed of the potential of quick weight regain when the treatment concludes," warns expert Dr. Susan Jebb.
Such speed of regain means a return to starting mass in about 18 months.
Analyzing Treatments
The analysis, which reviewed 37 of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with older methods.
Researchers note that people who shed pounds through dieting typically see a more gradual weight regain—around 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Doctors believe the mode of action of the injections is key to understanding the heightened rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means hunger is unsuppressed, making excessive eating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of weight regain, the therapy is often long-term.
This view is supported by drug manufacturers, who say that the findings "underscore the chronic nature of obesity," similar to managing conditions like high blood pressure.
Patient Testimonies
Users who have come off the jabs report a intense resurgence of cravings.
"It was like a trigger flipping and you're instantly extremely hungry," said a patient.
This challenge is exacerbated if patients have not developed sustainable lifestyle or habit changes during therapy.
Growing Interest
Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is greater among females than men.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
Finally, researchers stress that while the jabs are potent tools for weight loss, they are not a permanent fix and maintained weight loss likely depends on ongoing lifestyle management.
